Title: Septra - FDA prescribing information, side effects and uses
Headings: Septra
Septra
On This Page
Septra Description
Septra - Clinical Pharmacology
Geriatric Pharmacokinetics:
Microbiology:
Susceptibility Testing:
Indications and Usage for Septra
Urinary Tract Infections:
Acute Otitis Media:
Acute Exacerbations of Chronic Bronchitis in Adults:
Travelers' Diarrhea in Adults:
Shigellosis:
Pneumocystis Carinii Pneumonia:
Contraindications
Warnings
Adjunctive Treatment with Leucovorin for Pneumocystis jiroveci pneumonia
Precautions
General
Use in the Elderly:
Use in the Treatment of and Prophylaxis for Pneumocystis carinii Pneumonia in Patients with Acquired Immunodeficiency Syndrome (AIDS):
Information for Patients:
Laboratory Tests:
Drug Interactions:
Drug/Laboratory Test Interactions:
Carcinogenesis, Mutagenesis, Impairment of Fertility:
Pregnancy
Teratogenic Effects:
Nonteratogenic Effects:
Nursing Mothers:
Pediatric Use:
Geriatric Use:
Adverse Reactions
Hematologic:
Allergic:
Gastrointestinal:
Genitourinary:
Metabolic:
Neurologic:
Psychiatric:
Endocrine:
Musculoskeletal:
Respiratory System:
Miscellaneous:
Overdosage
Acute:
Chronic:
Septra Dosage and Administration
Urinary Tract Infections and Shigellosis in Adults and Pediatric Patients and Acute Otitis Media in Pediatric Patients:
Acute Exacerbations of Chronic Bronchitis in Adults:
Travelers' Diarrhea in Adults:
Pneumocystis Carinii Pneumonia:
Treatment:
Prophylaxis:
How is Septra Supplied
REFERENCES
PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label
100 Tablets
PRINCIPAL DISPLAY PANEL - 20 Tablet Bottle Label
PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label
100 Tablets
PRINCIPAL DISPLAY PANEL - 500 Tablet Bottle Label
Frequently asked questions
More about Septra (sulfamethoxazole / trimethoprim)
Consumer resources
Professional resources
Other brands
Other Formulations
Related treatment guides

Content: Septra Description
Septra (trimethoprim and sulfamethoxazole) is a synthetic antibacterial combination product. Each Septra Tablet contains 80 mg trimethoprim and 400 mg sulfamethoxazole and the inactive ingredients docusate sodium (0.4 mg per tablet), FD&C Red No. 40, magnesium stearate, povidone, and sodium starch glycolate. Each Septra DS (double strength) Tablet contains 160 mg trimethoprim and 800 mg sulfamethoxazole and the inactive ingredients docusate sodium (0.8 mg per tablet), FD&C Red No. 40, magnesium stearate, povidone, and sodium starch glycolate. Each teaspoonful (5 mL) of Septra Suspension contains 40 mg trimethoprim and 200 mg sulfamethoxazole and the inactive ingredients alcohol 0.26%, methylparaben 0.1% and sodium benzoate 0.1% (added as preservatives), carboxymethylcellulose sodium, citric acid, FD&C Red No. 40 and Yellow No. 6, flavor, glycerin, microcrystalline cellulose, polysorbate 80, saccharin sodium, and sorbitol. Each teaspoonful (5 mL) of Septra Grape Suspension contains 40 mg trimethoprim and 200 mg sulfamethoxazole and the inactive ingredients alcohol 0.26%, methylparaben 0.1%, and sodium benzoate 0.1% (added as preservatives), carboxymethylcellulose sodium, citric acid, FD&C Red No. 40 and Blue No.